-
Modified Gwakjeongtang for Diarrhea-Predominant Irritable Bowel Syndrome: Study Protocol for a Randomized, Double-Blind, Placebo-Controlled, Pilot Clinical Trial
22 Apr 2024 07:48 GMT
… medications such as loperamide, ramosetron, and rifaximin … antipsychotics, antidepressants, anti-anxiety medications, Z-drugs, and narcotic … blinded randomized controlled trial. Trials. 2021;22(1 … treatment; 2012. Available from: https://www.fda …
-
Drug shortages in U.S. reach a record high
13 Apr 2024 07:53 GMT
… medicines affected are popular diabetes drug Ozempic, lifesaving allergy treatment … pharmaceutical supply chain that makes it difficult for generic drugmakers … and intensive-care doctor at Emory University … . New shortages include Rifaximin tablets, which are …
-
Court of Appeals for the Federal Circuit Issues Ruling in Norwich Case that Prevents FDA Approval of Norwich’s Abbreviated New Drug Application Until 2029
11 Apr 2024 17:59 GMT
… and its gastroenterology business Salix Pharmaceuticals, today announced that the … Delaware that had denied Norwich Pharmaceuticals, Inc.'s motion … Drug Administration (FDA) from approving its abbreviated new drug application (ANDA) for XIFAXAN (rifaximin …
-
Bausch wins US appeal to block Alvogen generic of diarrhea drug
11 Apr 2024 16:52 GMT
… of
Bausch's diarrhea treatment Xifaxan until 2029.
A Delaware federal … separately agreed to allow Xifaxan generics from
Teva Pharmaceuticals, Sun Pharmaceuticals and
Sandoz starting … sought to force the FDA
to fully approve its drug.
(Reporting by Blake …
-
Bausch Health sues Amneal Pharmaceuticals over Xifaxan patent
08 Apr 2024 23:15 GMT
… Pharmaceuticals over Xifaxan.
The lawsuit alleges Amneal submitted an Abbreviated New Drug … Application to the FDA for approval … in the FDA's Orange Book for Xifaxan are … month stay of any potential FDA approval for Amneal…
-
Bausch Health Announces Patent Lawsuit Against Amneal Pharmaceuticals
05 Apr 2024 23:29 GMT
… Amneal Pharmaceuticals, LLC, Amneal Pharmaceuticals Private Limited, and Amneal Pharmaceuticals, Inc … stating that Amneal submitted an Abbreviated New Drug … Drug Administration (FDA) seeking approval to market a generic version of XIFAXAN® (rifaximin …
-
Primary Sclerosing Cholangitis Market Report 2032: Epidemiology, Therapies, Latest FDA, PDMA Approvals by DelveInsight
03 Apr 2024 11:00 GMT
… . Falk Pharma, Mirum Pharmaceuticals, Pliant Therapeutics, NGM … Sclerosing Cholangitis Drugs Uptake and … trials exploring pharmacotherapy over many years, finding a safe and effective medical treatment … agents, such as rifaximin, tetracycline, minocycline, …
-
FDA Approved Drug Products Approval List March 2024
30 Mar 2024 10:39 GMT
Approval Date Drug Name Submission Active … #214369 ORIG-1 RIFAXIMIN NORWICH PHARMACEUTICALS INC Tentative Approval … #761044 SUPPL-13 USTEKINUMAB JANSSEN BIOTECH Approval 03/18 … 213721 SUPPL-15 PRALSETINIB BLUEPRINT MEDICINES Labeling Approval 03…
-
Rifaximin Market Is Dazzling Worldwide with Major Giants AbbVie, LUPIN, Actavis Pharma, Wanbury
23 Mar 2024 14:23 GMT
… (Japan), Takeda Pharmaceuticals (Japan), Amneal Pharmaceuticals (United States), Torrent Pharmaceuticals Ltd. (India … ) by End User (Hospital, Drug Store) and by Geography (North … place in the pharmaceutical industry. The efficacy of Rifaximin in treating …
-
Which medications cause heartburn?
18 Mar 2024 14:07 GMT
… drug-induced heartburn, and when to contact a doctor.
Certain medications … amoxicillin
metronidazole
ciprofloxacin
rifaximin
Learn more about … .
Tricyclic antidepressants
Doctors may prescribe tricyclic antidepressants (TCAs) … a better treatment option and may …